Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s): TBRIF

Technology Scientific & Technical Instruments

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.

TSXV:THRM - Post by User

Therma Bright Inc > Under $.10 by end of this week ?

Bullboard Posts

Comment by FREEDOM55on Mar 14, 2022 3:08pm

88 Views

Post# 34512682

RE:Under $.10 by end of this week ?

Crackdown 2020 wrote

Under $.10 by end of this week ?

Very Doable!!
imho

LOL! That is what your boyfriend says about you ! And you like it!!

Bullboard Posts

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide

Invest wiser with BMO's InvestorLine Platform features

Invest wiser with BMO's InvestorLine Platform features

Eminent acquires promising Nevada gold project

Eminent acquires promising Nevada gold project

The top 10 Canadian medical stocks

The top 10 Canadian medical stocks

Anaergia expands relationship with PepsiCo

Anaergia expands relationship with PepsiCo